Literature DB >> 1417136

Correlation of antibodies to ribosomal P protein with psychosis in patients with systemic lupus erythematosus.

Y Nojima1, S Minota, A Yamada, F Takaku, S Aotsuka, R Yokohari.   

Abstract

Ninety one Japanese patients with systemic lupus erythematosus (SLE) were studied to determine the clinical significance of antibodies to ribosomal P protein (anti-P). Anti-P was detected by western blotting in 38 of 91 patients (42%). Clinical symptoms of SLE were compared between patients with and without anti-P. The occurrence of lupus psychosis was significantly higher in patients with anti-P than in those without anti-P (9/38 v 1/53). No significant association was found between anti-P and other symptoms of SLE. These data strongly support the suggestion proposed by previous workers that anti-P is a marker autoantibody for the development of lupus psychosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1417136      PMCID: PMC1004836          DOI: 10.1136/ard.51.9.1053

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  12 in total

Review 1.  The natural history of systemic lupus erythematosus by prospective analysis.

Authors:  D Estes; C L Christian
Journal:  Medicine (Baltimore)       Date:  1971-03       Impact factor: 1.889

2.  Nervous system involvement in systemic lupus erythematosus.

Authors:  T Gibson; A R Myers
Journal:  Ann Rheum Dis       Date:  1975-10       Impact factor: 19.103

3.  Antineuronal antibodies in neuropsychiatric systemic lupus erythematosus.

Authors:  A How; P B Dent; S K Liao; J A Denburg
Journal:  Arthritis Rheum       Date:  1985-07

4.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

5.  Association of IgG anti-brain antibodies with central nervous system dysfunction in systemic lupus erythematosus.

Authors:  H A Wilson; J B Winfield; R G Lahita; D Koffler
Journal:  Arthritis Rheum       Date:  1979-05

6.  Clinical and serologic associations of the antiribosomal P protein antibody.

Authors:  E Bonfa; K B Elkon
Journal:  Arthritis Rheum       Date:  1986-08

7.  Identification of an acidic ribosomal protein reactive with anti-Sm autoantibody.

Authors:  Y Nojima; S Minota; A Yamada; F Takaku
Journal:  J Immunol       Date:  1989-09-15       Impact factor: 5.422

8.  Neurocytotoxic antibodies in serum of patients with systemic lupus erythematosus.

Authors:  H G Bluestein
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

9.  Autoantibodies in the cerebrospinal fluid of patients with systemic lupus erythematosus.

Authors:  S J Golombek; F Graus; K B Elkon
Journal:  Arthritis Rheum       Date:  1986-09

10.  Lupus autoantibodies target ribosomal P proteins.

Authors:  K B Elkon; A P Parnassa; C L Foster
Journal:  J Exp Med       Date:  1985-08-01       Impact factor: 14.307

View more
  19 in total

1.  Technical and clinical evaluation of anti-ribosomal P protein immunoassays.

Authors:  M Mahler; K Kessenbrock; J Raats; M J Fritzler
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

Review 2.  The Bidirectional Relationship of Depression and Inflammation: Double Trouble.

Authors:  Eléonore Beurel; Marisa Toups; Charles B Nemeroff
Journal:  Neuron       Date:  2020-06-17       Impact factor: 17.173

3.  The expression of acidic ribosomal phosphoproteins on the surface membrane of different tissues in autoimmune and normal mice which are the target molecules for anti-double-stranded DNA antibodies.

Authors:  K H Sun; W T Liu; S J Tang; C Y Tsai; S C Hsieh; T H Wu; S H Han; C L Yu
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

Review 4.  Neuropsychiatric lupus: new mechanistic insights and future treatment directions.

Authors:  Noa Schwartz; Ariel D Stock; Chaim Putterman
Journal:  Nat Rev Rheumatol       Date:  2019-03       Impact factor: 20.543

5.  The clinical relevance of antibodies to ribosomal-P common epitope in two targeted systemic lupus erythematosus populations: a large cohort of consecutive patients and patients with active central nervous system disease.

Authors:  A G Tzioufas; N G Tzortzakis; E Panou-Pomonis; K A Boki; M Sakarellos-Daitsiotis; C Sakarellos; H M Moutsopoulos
Journal:  Ann Rheum Dis       Date:  2000-02       Impact factor: 19.103

6.  International multicenter evaluation of autoantibodies to ribosomal P proteins.

Authors:  Michael Mahler; Kai Kessenbrock; Magdalena Szmyrka; Yoshinari Takasaki; Ignacio Garcia-De La Torre; Yehuda Shoenfeld; Falk Hiepe; Chen Shun-le; Carlos A von Mühlen; Henning Locht; Peter Höpfl; Allan Wiik; Westley Reeves; Marvin J Fritzler
Journal:  Clin Vaccine Immunol       Date:  2006-01

7.  Anti-dsDNA antibodies cross-react with ribosomal P proteins expressed on the surface of glomerular mesangial cells to exert a cytostatic effect.

Authors:  K H Sun; W T Liu; C Y Tsai; S J Tang; S H Han; C L Yu
Journal:  Immunology       Date:  1995-06       Impact factor: 7.397

8.  Association of anti-ribosomal P protein antibodies with neuropsychiatric and other manifestations of systemic lupus erythematosus.

Authors:  Ahmed M Abdel-Nasser; Rasha M Ghaleb; Jehan A Mahmoud; Wafaa Khairy; Refaat M Mahmoud
Journal:  Clin Rheumatol       Date:  2008-05-15       Impact factor: 2.980

9.  Significance of antibodies against the native ribosomal P protein complex and recombinant P0, P1, and P2 proteins in the diagnosis of Chinese patients with systemic lupus erythematosus.

Authors:  Jing Li; Ying Shen; Jing He; Rulin Jia; Xiujie Wang; Xiaosan Chen; Dahai Wang; Lei Han; Lei Zhu; Xiaofeng Chi; Sandra Saschenbrecker; Cornelia Dähnrich; Winfried Stöcker; Wolfgang Schlumberger; Zhan-Guo Li
Journal:  J Clin Lab Anal       Date:  2013-02-11       Impact factor: 2.352

10.  Clinical and serological associations of anti-ribosomal P0 protein antibodies in systemic lupus erythematosus.

Authors:  Yong-Jun Mei; Peng Wang; Chao Jiang; Tao Wang; Lin-Jie Chen; Zhi-Jun Li; Hai-Feng Pan
Journal:  Clin Rheumatol       Date:  2017-11-18       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.